Galectin Therapeutics Inc... (GALT)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

2.35

11.64%

Pre-market Dec 16, 2024, 05:54 AM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10	FY09	FY08	FY07	FY06	FY05	FY04	FY03	FY02	FY01	FY00
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	33.00K	32.00K	41.00K	36.00K	35.00K	-	1K	7.00K	7.00K	-	-	-	-	-	-	5.33M	6.46M	7.05M	-	-	-	-	-	-
Gross Profit	-33.00K	-32.00K	-41.00K	-36.00K	-35.00K	-	-1K	-7.00K	-7.00K	-	-	-	-	-	-	-5.33M	-6.46M	-7.05M	-	-	-	-	-	-
Operating Income	-38.07M	-38.35M	-30.18M	-23.44M	-13.44M	-13.60M	-16.25M	-21.48M	-20.08M	-15.43M	-12.10M	-9.90M	-10.41M	-4.88M	-6.09M	-5.33M	-6.46M	-7.05M	-6.66M	-7.30M	-4.94M	-3.29M	-2.18M	-170.00K
Interest Income	-	52.00K	3.00K	66.00K	231.00K	38.00K	24.00K	45.00K	52.00K	42.00K	16.00K	24.00K	18.00K	6.00K	3.00K	30.00K	102.00K	281.00K	111.00K	124.00K	68.92K	24.26K	24.92K	-
Pretax Income	-41.07M	-38.78M	-30.53M	-23.46M	-13.29M	-13.90M	-16.23M	-21.44M	-20.03M	-15.79M	-12.09M	-9.68M	-10.91M	-5.63M	-7.46M	-3.15M	-9.43M	-3.19M	-6.54M	-7.18M	-4.87M	-3.68M	-	-190.00K
Net Income	-41.07M	-39.20M	-30.98M	-23.52M	-13.38M	-13.90M	-16.23M	-21.44M	-20.03M	-15.79M	-12.09M	-9.68M	-10.91M	-5.63M	-7.46M	-3.15M	-9.43M	-3.19M	-6.54M	-7.18M	-4.87M	-3.68M	-3.97M	-190.00K
Selling & General & Admin	5.94M	6.62M	6.36M	5.47M	5.97M	7.13M	4.53M	6.16M	6.96M	7.00M	6.42M	5.37M	6.86M	3.82M	4.98M	3.55M	4.40M	4.03M	3.62M	4.26M	2.99M	1.80M	1.29M	70.00K
Research & Development	32.13M	31.74M	23.82M	17.98M	7.47M	6.47M	11.72M	15.32M	13.11M	8.43M	5.69M	4.53M	3.55M	1.07M	1.11M	1.77M	2.05M	3.02M	3.04M	3.04M	1.95M	1.48M	893.46K	100.00K
Other Expenses	-0.00	-	-	-	-	-	-	-	-	-	-	200.00K	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	38.07M	38.35M	30.18M	23.44M	13.44M	13.60M	16.25M	21.48M	20.08M	15.43M	12.10M	9.90M	10.41M	4.88M	6.09M	5.33M	6.46M	7.05M	6.66M	7.30M	4.94M	3.29M	2.18M	170.00K
Interest Expense	2.56M	1.03M	489.00K	87.00K	87.00K	336.00K	12.00K	-	-	-	-	-	-	-	-	-	350.00K	1.85M	-	-	3.88K	415.42K	-	-
Selling & Marketing Expenses	44.00K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost & Expenses	38.07M	38.35M	30.18M	23.44M	13.44M	13.60M	16.25M	21.48M	20.08M	15.43M	12.10M	9.90M	10.41M	4.88M	6.09M	5.33M	6.46M	7.05M	6.66M	7.30M	4.94M	3.29M	2.18M	170.00K
Income Tax	-	424.00K	448.00K	51.00K	87.00K	-123.14K	24.00K	-	-	-52.00K	16.00K	200.00K	506.00K	746.00K	1.37M	-2.17M	2.98M	-3.85M	-	-	-	-	1.79M	-
Shares Outstanding (Basic)	60.16M	59.39M	58.53M	57.03M	52.24M	39.41M	35.52M	29.22M	24.12M	21.85M	16.87M	15.13M	11.99M	9.38M	8.05M	7.80M	6.50M	4.75M	4.55M	4.29M	3.56M	2.73M	2.27M	2.06M
Shares Outstanding (Diluted)	60.16M	59.39M	58.53M	57.03M	52.24M	39.41M	35.52M	29.22M	24.12M	21.85M	16.87M	15.13M	11.99M	9.38M	8.05M	7.80M	6.50M	4.75M	4.55M	4.29M	3.56M	2.73M	2.27M	2.06M
EPS (Basic)	-0.74	-0.66	-0.53	-0.41	-0.26	-0.35	-0.46	-0.73	-0.83	-0.72	-0.72	-0.64	-0.91	-0.6	-0.93	-0.4	-1.45	-0.67	-1.44	-1.67	-1.37	-1.35	-1.75	-0.09
EPS (Diluted)	-0.74	-0.66	-0.53	-0.41	-0.26	-0.35	-0.46	-0.73	-0.83	-0.72	-0.72	-0.64	-0.91	-0.6	-0.93	-0.4	-1.45	-0.67	-1.44	-1.67	-1.37	-1.35	-1.75	-0.09
EBITDA	-202.00K	-37.71M	-30.00M	-23.34M	-13.17M	-13.56M	-16.23M	-21.47M	-20.07M	-15.78M	-12.08M	-9.67M	-10.91M	-5.62M	-7.42M	-3.10M	-9.02M	-1.28M	-6.77M	-7.10M	-4.85M	-3.08M	-2.02M	-190.00K
Depreciation & Amortization	38.07M	32.00K	41.00K	36.00K	35.00K	1K	1K	7.00K	7.00K	10.00K	12.00K	9.00K	9.00K	12.00K	37.00K	49.00K	64.00K	67.00K	81.00K	81.00K	89.17K	211.18K	159.47K	-20.00K